Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with…
Ahammune’s investigational new drug for vitiligo- AB1001 has mechanism of action that targets pathways involved in triggering…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.